GOLPH2-regulated oncolytic adenovirus, GD55, exerts strong killing effect on human prostate cancer stem-like cells in vitro and in vivo
Authors:
Open Access
- 7 September 2017
- journal article
- research article
- Published by Springer Nature in Acta Pharmacologica Sinica
- Vol. 39 (3) , 405-414
Abstract
GOLPH2 (also called GP73) is a Golgi glycoprotein, which has been identified as a novel tumor marker upregulated in various cancers, including prostate cancer (PCa). GD55 is a novel GOLPH2-regulated oncolytic adenovirus that exhibits a strong killing effect on hepatoma cells. Here, we investigate the antitumor effect of GD55 on prostate cancer stem cell (CSC)-like cells in vitro and in vivo. Prostate CSC-like sphere cells were acquired and enriched by culturing DU145, LNCap or P3 prostate cancer cells in suspension. The prostate CSC-like sphere cells were capable of self-renewal, differentiation and quiescence, displaying tumorigenic feature and chemo-resistance to 5-FU, doxorubicin and DDP. Treatment with GD55 (1, 5, 10 MOI) dose-dependently suppressed the viability of DU145 sphere cells, which was a more pronounced compared to its cytotoxic action on the parental DU145 cells. In a mouse xenograft prostate CSC-like model, intratumoral injection of GD55 markedly suppressed the growth rate of xenograft tumors and induced higher levels of cell death and necrosis within the tumor tissues. Our results demonstrate that GD55 infection exerts strong anticancer effects on prostate CSC-like cells in vitro and in vivo, and has a potential to be used in the clinical therapy of PCa.Keywords
This publication has 36 references indexed in Scilit:
- GP73 is down-regulated in gastric cancer and associated with tumor differentiationWorld Journal of Surgical Oncology, 2013
- Prominin 1/CD133 Endothelium Sustains Growth of Proneural GliomaPLOS ONE, 2013
- Enrichment of Prostate Cancer Stem-Like Cells from Human Prostate Cancer Cell Lines by Culture in Serum-Free Medium and ChemoradiotherapyInternational Journal of Biological Sciences, 2013
- Anti-angiogenic therapy increases intratumoral adenovirus distribution by inducing collagen degradationGene Therapy, 2012
- NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivationOncogene, 2011
- Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-κB signallingNature Communications, 2011
- Targeting Cancer-initiating Cells With Oncolytic VirusesMolecular Therapy, 2009
- The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populationsProceedings of the National Academy of Sciences, 2009
- CD44+CD24− prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosisBritish Journal of Cancer, 2008
- Tumour stem cells and drug resistanceNature Reviews Cancer, 2005